BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

GlycoGenesys, Inc. (Formerly SafeScience, Inc.) 

Park Square Building
31 St. James Avenue, Suite 520
Boston  Massachusetts  02116  U.S.A.
Phone: 617-422-0674 Fax: 617-422-0675


SEARCH JOBS


Industry
Biotechnology

Segment
Pharmaceuticals





 Company News
GlycoGenesys, Inc. (Formerly SafeScience, Inc.) (GLGS) Files For Chapter 11, Says CEO Resigns 2/3/2006 10:47:58 AM    More...
GlycoGenesys, Inc. (Formerly SafeScience, Inc.) (GLGS) Initiates Additional Prestigious Medical Site For GCS-100 Phase I/II Multiple Myeloma Clinical Trial 11/17/2005 11:55:54 AM    More...
GlycoGenesys, Inc. (Formerly SafeScience, Inc.) (GLGS) To Present At The Bio-Europe 2005 Partnering Conference 11/4/2005 1:22:18 PM    More...
GlycoGenesys, Inc. (Formerly SafeScience, Inc.) (GLGS) Announces $20.0 Million Common Stock Purchase Agreement With Fusion Capital 10/24/2005 11:01:47 AM    More...
GlycoGenesys, Inc. (Formerly SafeScience, Inc.) (GLGS) Comments On 2004 Year-End Financial Results; Annual Conference Call Scheduled On April 7, 2005 10/19/2005 5:13:14 PM    More...
GlycoGenesys, Inc. (Formerly SafeScience, Inc.) (GLGS) Initiates Phase I/II Clinical Trial Of GCS-100LE In Multiple Myeloma At Dana-Farber Cancer Institute; Trial Based On Promising Pre-Clinical Data 10/19/2005 5:13:12 PM    More...
GlycoGenesys, Inc. (Formerly SafeScience, Inc.) (GLGS) Conference Call Alert For April 7, 2005 10/19/2005 5:13:12 PM    More...
GlycoGenesys, Inc. (Formerly SafeScience, Inc.) (GLGS) To Make Presentation At Glycomics And Carbohydrates In Drug Development Conference 10/19/2005 5:13:04 PM    More...
GlycoGenesys, Inc. (Formerly SafeScience, Inc.) (GLGS) Closes On First Of Two Tranches In A $6,500,000 Financing 10/19/2005 5:13:01 PM    More...
GlycoGenesys, Inc. (Formerly SafeScience, Inc.) (GLGS) Senior Scientist To Make Presentation At 229th American Chemical Society Meeting 10/19/2005 5:13:01 PM    More...
1234567

//-->